News
2021 New Products Launched: ZigaBio B2F
We are excited to introduce ZigaBio B2F, one of our innovative new products launched in 2021！
Developed using advanced bioengineering technology, ZigaBio B2F is derived from a carefully selected strain of Bacillus subtilis, obtained through a controlled fermentation process.
What sets ZigaBio B2F apart is our exclusive purification process, which effectively increases the concentration of Keratinase—an enzyme known for its skin-renewing properties. At the same time, this process eliminates unwanted by-products that may cause skin irritation or allergic reactions, ensuring the ingredient is both potent and gentle on the skin.
ZigaBio B2F reflects our ongoing commitment to combining biotechnology and skin safety, delivering effective solutions for modern skincare formulations.
ZigaBio B2F is from the selected fermented Bacillus subtilis from red wine dreg by advanced bioengineering process, it contains the Keratinase to decompose the keratin effectively.
The exclusive process can remove the irritants or allergens of the Bacillus subtilis metabolites. Passed the in-vivo and in-vitro testing, scientifically proof of skin improvement.
RNA interference, RNAi
Using the small fraction to interfere with siRNA and select the stable, superior strain by gene silencing study.
Multi-Stage Fermentation System
B2F enzyme can effectively increase the yield by using the multi-stage fermentation system. By using the high concentration gradient separation method to ensure our product has the highest concentration of B2F.
